- Home
- TRSG vs RADX Comparison
TRSG vs RADX Comparison
Compare TRSG & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- RADX
- Stock Information
- Founded
- TRSG 1996
- RADX 2021
- Country
- TRSG Singapore
- RADX Australia
- Employees
- TRSG N/A
- RADX N/A
- Industry
- TRSG
- RADX
- Sector
- TRSG
- RADX
- Exchange
- TRSG NYSE
- RADX NYSE
- Market Cap
- TRSG 27.0M
- RADX 32.5M
- IPO Year
- TRSG 2024
- RADX N/A
- Fundamental
- Price
- TRSG $1.60
- RADX $4.25
- Analyst Decision
- TRSG
- RADX Strong Buy
- Analyst Count
- TRSG 0
- RADX 2
- Target Price
- TRSG N/A
- RADX $13.50
- AVG Volume (30 Days)
- TRSG 4.8K
- RADX 19.3K
- Earning Date
- TRSG 05-14-2025
- RADX 02-26-2025
- Dividend Yield
- TRSG N/A
- RADX N/A
- EPS Growth
- TRSG N/A
- RADX N/A
- EPS
- TRSG N/A
- RADX N/A
- Revenue
- TRSG $12,810,249.00
- RADX $204,609.00
- Revenue This Year
- TRSG N/A
- RADX N/A
- Revenue Next Year
- TRSG N/A
- RADX N/A
- P/E Ratio
- TRSG N/A
- RADX N/A
- Revenue Growth
- TRSG N/A
- RADX N/A
- 52 Week Low
- TRSG $1.00
- RADX $3.50
- 52 Week High
- TRSG $4.57
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- RADX N/A
- Support Level
- TRSG N/A
- RADX N/A
- Resistance Level
- TRSG N/A
- RADX N/A
- Average True Range (ATR)
- TRSG 0.00
- RADX 0.00
- MACD
- TRSG 0.00
- RADX 0.00
- Stochastic Oscillator
- TRSG 0.00
- RADX 0.00
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.